MedPath
FDA Product

RIVASTIGMINE TARTRATE

Product approved by U.S. Food and Drug Administration (US)

Basic Information

RIVASTIGMINE TARTRATE

33342-092

Regulatory Information

33342-092

ANDA203148

C73584

August 24, 2022

USA

These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES . RIVASTIGMINE TARTRATE capsules, for oral use Initial U.S. Approval: 2000

Human Prescription Drug Label

7

Company Information

862128535

Active Ingredients

RIVASTIGMINE TARTRATE

Quantity: 6 mg in 1 1

Code: 9IY2357JPE

Class Code: ACTIM

MAGNESIUM STEARATE

Code: 70097M6I30

Class Code: IACT

SILICON DIOXIDE

Code: ETJ7Z6XBU4

Class Code: IACT

CELLULOSE, MICROCRYSTALLINE

Code: OP1R32D61U

Class Code: IACT

GELATIN

Code: 2G86QN327L

Class Code: IACT

TITANIUM DIOXIDE

Code: 15FIX9V2JP

Class Code: IACT

SODIUM LAURYL SULFATE

Code: 368GB5141J

Class Code: IACT

FERRIC OXIDE RED

Code: 1K09F3G675

Class Code: IACT

FERRIC OXIDE YELLOW

Code: EX438O2MRT

Class Code: IACT

HYPROMELLOSES

Code: 3NXW29V3WO

Class Code: IACT

Active Moieties

RIVASTIGMINE

Code: PKI06M3IW0

© Copyright 2025. All Rights Reserved by MedPath